The artificial disc replacement market is expected to grow at a compound annual growth rate of 12.3% between 2023 and 2030, according to Vantage Market Research.
By 2030, the global artificial disc replacement market is expected to reach $1.3 billion, according to a March 11 news release. One key growth driver is the increased adoption of disc replacement, but the market also faces the challenges of developing devices that best mimic the nature of the human spine.
Vantage Market Research identified prominent leaders in the disc replacement market including Medtronic, Orthofix, Globus Medical and Aesculap.
Here are four spinal devices that have earned FDA approval, as reported by Becker’s since Jan. 24:
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will…
Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its…